23 May 2013
Keywords: completes, omrix, tender, offer, health, care, major
Article | 12 January 2009
US health care major Johnson & Johnson says that stockholders of Omrix Biopharmaceuticals, for which it recently made a take-over offer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
22 May 2013
© 2013 thepharmaletter.com